More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$116.35B
EPS
4.07
P/E ratio
22.5
Price to sales
3.12
Dividend yield
3.166%
Beta
0.558709
Previous close
$91.62
Today's open
$93
Day's range
$90.26 - $93
52 week range
$73.31 - $106.33
show more
CEO
Geoffrey S. Martha
Employees
95000
Headquarters
Galway,
Exchange
New York Stock Exchange
Shares outstanding
1.28B
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Here are the stocks to favor in the fourth quarter — and those you should avoid
Large caps tend to outperform small caps as year's end approaches.
Market Watch • Sep 10, 2026

Wall Street Isn't Talking About High-Yield Medtronic Stock -- Here's Why It Should Be
Medtronic is one of the world's largest medical device companies. Medtronic has reshaped its business, with a focus on returning to growth.
The Motley Fool • Sep 9, 2026

Medtronic Is on the Cusp of Becoming a Dividend King. Is the Stock a Buy for Income Investors?
Factors such as the prospect of slow dividend growth could make Medtronic stock less attractive to income-focused investors. For investors interested in both income and capital growth, much suggests that Medtronic remains a strong choice to buy and hold over the next few years.
The Motley Fool • Sep 9, 2026

Medtronic Raises 2027 Outlook as Broad-Based Growth Gains Momentum
MDT lifts its 2027 outlook as broad-based growth accelerates, but margin pressure and competition could test momentum.
Zacks Investment Research • Sep 9, 2026

Medtronic Touts AI, Robotics and Ablation Growth at Wells Fargo Conference
Medtronic NYSE: MDT executives said the medical device maker is seeing accelerating growth across major franchises and emerging product categories, supported by innovation in artificial intelligence, robotics and new therapies.
MarketBeat • Sep 9, 2026

Medtronic plc (MDT) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Medtronic plc (MDT) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Seeking Alpha • Sep 8, 2026

Is Medtronic Worth Buying as Growth Improves but Risks Stay Elevated?
MDT's stronger growth and earnings outlook improve its case, but margin, currency and execution risks keep investors selective.
Zacks Investment Research • Sep 8, 2026

Jim Cramer says investors are too focused on AI stocks. Here's where he says to look instead
CNBC's Jim Cramer said investors should look beyond the AI data-center trade as compelling opportunities emerge in other areas of the market. He highlighted aerospace, fintech, health care and energy stocks.
CNBC • Sep 8, 2026

Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the appointment of Sean M. Salmon to its Board of Directors, effective September 8, 2026. Mr. Salmon brings over three decades of global leadership experience in the medical device and pharmaceutical industries, culminating in more than 20 years at Medtronic plc (NYSE: MDT). He most recently served as Executive Vice President and President of its Cardiovascular Portf.
Business Wire • Sep 8, 2026

Medtronic executives to speak at upcoming investor conferences
GALWAY, Ireland, Sept. 4, 2026 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the following investor conferences: 2026 Wells Fargo Healthcare Conference Tuesday, September 8, 2026, at ~11:45 a.m.
PRNewsWire • Sep 4, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Medtronic plc. commission-free¹. Build wealth for the long term using automated trading and transfers.